Xconomy.com -- Google is the undisputed king of Internet search and advertising, but its second act as a company might be to invent a new computer model for efficiently discovering targeted antibody drugs.
“Google is committing incredible resources to it. Incredible resources,” says Tillman Gerngross, the founder and CEO of Lebanon, NH-based Adimab. “The infrastructure alone is in the millions of dollars of raw computational power.”